Biomagnetic imaging company Genetesis closes $7.5 milion in Series A financing

(CincyTech) Genetesis, a medical device company focused on using biomagnetic imaging to enable rapid, noninvasive and accurate chest pain triage, has closed an oversubscribed round of $7.5 million in Series A financing. CincyTech led the round with participation from existing investors including Mark Cuban's Radical Investments, and new investors including Ohio Innovation Fund and Raptor Group.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news